Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

covance logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:

  • Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)
  • Drug Substance Production: Primary Process Development, Drug Substance Production

Main Service Areas:
Bioanalytical, Clinical, Preclinical

Services & Capabilities:
Pharmacology, bioanalysis and biopharmaceutical CMC (small and large molecule), ADME, nonclinical safety assessment, program management, clinical pharmacology and Phase I/IIa trials, early clinical studies, proof-of-concept studies, Phase IIb/III studies, risk-based monitoring, post-registration and Phase IV studies.

Therapeutic Areas:
Inflammation, oncology, cardiovascular/metabolic, neuroscience, infectious disease, analgesic, anti-infectives, CNS, dermatology, GI, hematology, hormonal therapy, immunology, ocular, renal disease, respiratory disease.

Joe Herring

chairman and chief executive officer

“Covance’s commitment to science and its promise of a healthier world drives us to deliver real solutions to our clients. Our teams of talented professionals and innovative and integrated processes produce high-quality data on time or early, and on budget or below — helping
our clients get their new medicines to patients sooner.”